UnknownNot Applicable

A Registry of Peripartum Cardiomyopathy in Turkey

Turkey (Türkiye)50 participantsStarted 2017-07-02

Plain-language summary

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient above 18 years of age * Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period * Ejection fraction less than 45% documented with echocardiography Exclusion Criteria: * Patients with any other known cardiac pathology

What they're measuring

Pregnancy outcome

Timeframe: 5 months after delivery

Trial details

NCT IDNCT03364140

SponsorEge University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-01-15

Contact for this trial

Meral Kayikcioglu, MD

+902323905448 meral.kayikcioglu@gmail.com

View on ClinicalTrials.gov More Peripartum Cardiomyopathy trials